Dr. Paul Mulholland is a Consultant at the National Hospital for Neurology and Neurosurgery, UCLH. He is a medical oncologist who specialises in the treatment of brain cancer. His doctoral research was in genomic profiling in brain cancer at CRUK LRI. He now runs a clinical trial portfolio at UCLH and nationally of novel agents in brain cancer. His research focuses on developing biomarkers and new therapies in brain cancer.